デフォルト表紙
市場調査レポート
商品コード
1619192

腹膜透析の市場規模・シェア・成長分析 (製品別、モダリティ別、適用疾患別、エンドユーザー別、地域別):産業予測 (2024~2031年)

Peritoneal Dialysis Market Size, Share, Growth Analysis, By Offering, By Modality (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), By Disease Indication, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
腹膜透析の市場規模・シェア・成長分析 (製品別、モダリティ別、適用疾患別、エンドユーザー別、地域別):産業予測 (2024~2031年)
出版日: 2024年12月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の腹膜透析の市場規模は、2022年に84億7,000万米ドルと評価され、2023年の89億4,000万米ドルから2031年には138億3,000万米ドルに成長し、予測期間 (2024-2031年) のCAGRは5.6%で成長する見通しです。

腹膜透析 (PD) 市場は、特に腎機能が残存している患者にとって、従来の血液透析に対する優位性によって大きな成長を遂げています。PDは柔軟な在宅治療が可能で、通院や厳しい食事制限を最小限に抑えることができるため、患者にとって魅力的な治療法となっています。現在、在宅透析、特にPDの利用が増加していることは、2023年から2019年にかけて、2年未満の末期腎臓病 (ESKD) 患者における利用率が14.8%から20%に上昇したことからも明らかです。しかし、特に高齢患者においては、サイクラー装置に関する技術恐怖症のため、商業的課題が残っています。COVID-19以降、医療需要の高まり、革新的なソリューションに対する需要、政府の支援策が世界のPD市場を推進し、腎臓ケアにおける関連性の高まりをさらに際立たせると予想されます。

目次

イントロダクション

  • 分析目的
  • 市場範囲
  • 定義

分析手法

  • 情報調達
  • 二次・一次データの手法
  • 市場規模予測
  • 市場の想定と制約

エグゼクティブサマリー

  • 市場の概要と展望
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析

市場の主な考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場魅力度指数 (2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • 貿易分析
  • 規制分析
  • 特許分析
  • ケーススタディ分析

世界の腹膜透析の市場規模・CAGR:提供内容別 (2024~2031年)

  • 市場概要
  • 腹膜透析製品
    • 腹膜透析向け溶液バッグ
    • 腹膜透析機
    • 腹膜透析用カテーテル
    • 腹膜透析用トランスファーセット
    • その他の腹膜透析製品
  • 腹膜透析サービス

世界の腹膜透析の市場規模・CAGR:モダリティ別 (2024~2031年)

  • 市場概要
  • 持続携行式腹膜透析 (CAPD)
  • 自動腹膜透析 (APD)

世界の腹膜透析の市場規模・CAGR:適用疾患別 (2024~2031年)

  • 市場概要
  • 末期腎疾患
  • 急性腎障害
  • その他の疾患

世界の腹膜透析の市場規模・CAGR:エンドユーザー別 (2024~2031年)

  • 市場概要
  • 在宅医療
  • 病院・独立透析センター
  • その他のエンドユーザー

世界の腹膜透析の市場規模・CAGR (2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要企業が採用した戦略
  • 市場の近年の動向
  • 主要企業の市場シェア(2023年)
  • 主要企業のプロファイル
    • 企業概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較 (2021~2023年)

主要企業プロファイル

  • Fresenius Medical Care AG (ドイツ)
  • Baxter International Inc. (米国)
  • Medtronic PLC (アイルランド)
  • DaVita Inc. (米国)
  • Becton, Dickinson and Company (米国)
  • Terumo Corporation (日本)
  • Utah Medical Products, Inc. (米国)
  • Diaverum AB (スウェーデン)
  • Medionics (米国)
  • Newsol Technologies Inc. (米国)
  • Apollo Dialysis Pvt. Ltd. (インド)
  • U.S. Renal Care, Inc. (米国)
  • Northwest Kidney Centers (米国)
  • Relavo (米国)
  • Mitra Industries Pvt. Ltd. (インド)
  • JMS Co., Ltd. (日本)
  • Amecath (中国)
  • Polymedicure (インド)
  • Huaren Pharmaceutical (中国)
  • Awak Technologies (シンガポール)

結論と推奨事項

目次
Product Code: SQMIG35D2183

Global Peritoneal Dialysis Market size was valued at USD 8.47 billion in 2022 and is poised to grow from USD 8.94 billion in 2023 to USD 13.83 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2024-2031).

The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, particularly for patients with remaining renal function. PD allows for flexible, home-based treatment, minimizing hospital visits and tough dietary restrictions, making it appealing to patients. Today's increasing use of home dialysis, particularly PD, is evident as its utilization rose from 14.8% to 20% among patients with less than two years of end-stage kidney disease (ESKD) between 2023 and 2019. However, commercial challenges persist, especially among older patients, due to technophobia regarding cycler equipment. Post-COVID-19, rising healthcare demands, demand for innovative solutions, and supportive government initiatives are expected to propel the global PD market, further highlighting its growing relevance in renal care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peritoneal Dialysis Market Segmental Analysis

Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is driven by several key factors, including the rising prevalence of end-stage renal disease (ESRD), advancements in the technology of peritoneal dialysis cyclers, and an increasing demand for home dialysis treatment options. Peritoneal dialysis offers numerous advantages such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, ease of use, and fewer dietary restrictions, all of which contribute to its global market growth. Furthermore, the escalating need for home care dialysis services reflects the growing trend of treating both acute and chronic kidney disease patients in outpatient or home settings. With over 800 million individuals affected by chronic kidney disease worldwide, the demand for effective renal home treatments continues to rise, particularly in low- and middle-income countries where the burden is disproportionately significant.

Restraints in the Global Peritoneal Dialysis Market

The global peritoneal dialysis market faces several significant restraints that hinder its growth potential. Key challenges include a heightened risk of infections and complications associated with treatment failure, which can deter patients and healthcare providers from opting for this method. Additionally, the necessity for permanent catheter insertion outside the body raises concerns about long-term health risks and patient comfort. Furthermore, the complex and often lengthy approval processes for new dialysis devices can stifle innovation and limit the availability of improved treatment options. Together, these factors contribute to a cautious approach towards the adoption of peritoneal dialysis solutions in the healthcare sector.

Market Trends of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is witnessing significant growth, spurred by the rising prevalence of End Stage Renal Disease (ESRD) and associated conditions such as diabetes and hypertension. Increased public awareness and government initiatives aimed at expanding access to dialysis options are further enhancing market dynamics. The demand for advanced treatment technologies is also on the rise, reflecting a shift towards more efficient and patient-friendly solutions. Additionally, the growing adoption of peritoneal dialysis in developing regions like China and India presents new opportunities, positioning the market for sustained expansion in the coming years, driven by evolving healthcare needs globally.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Trade Analysis
  • Regulatory Analysis
  • Patent Analysis
  • Case Study Analysis

Global Peritoneal Dialysis Market Size by Offering & CAGR (2024-2031)

  • Market Overview
  • Peritoneal Dialysis Products
    • Peritoneal Dialysis Solution Bags
    • Peritoneal Dialysis Machines
    • Peritoneal Dialysis Catheters
    • Peritoneal Dialysis Transfer Sets
    • Other Peritoneal Dialysis Products
  • Peritoneal Dialysis Services

Global Peritoneal Dialysis Market Size by Modality & CAGR (2024-2031)

  • Market Overview
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Global Peritoneal Dialysis Market Size by Disease Indication & CAGR (2024-2031)

  • Market Overview
  • End-Stage Renal Disease
  • Acute Kidney Injury
  • Other Diseases

Global Peritoneal Dialysis Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Home Care Settings
  • Hospitals & Independent Dialysis Centers
  • Other End Users

Global Peritoneal Dialysis Market Size & CAGR (2024-2031)

  • North America (Offering, Modality, Disease Indication, End User)
    • USA
    • Canada
  • Europe (Offering, Modality, Disease Indication, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Offering, Modality, Disease Indication, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Offering, Modality, Disease Indication, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Offering, Modality, Disease Indication, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Fresenius Medical Care AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DaVita Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Utah Medical Products, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diaverum AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medionics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Newsol Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Dialysis Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • U.S. Renal Care, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Northwest Kidney Centers (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Relavo (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mitra Industries Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JMS Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amecath (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polymedicure (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Huaren Pharmaceutical (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Awak Technologies (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations